Cargando…

Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)

Using a canine model of classical late-infantile neuronal ceroid lipofuscinosis (CLN2 disease), a study was conducted to evaluate the potential pharmacological activity of recombinant human tripeptidyl peptidase-1 (rhTPP1) enzyme replacement therapy administered directly to the cerebrospinal fluid (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katz, Martin L, Coates, Joan R, Sibigtroth, Christine M, Taylor, Jacob D, Carpentier, Melissa, Young, Whitney M, Wininger, Fred A, Kennedy, Derek, Vuillemenot, Brian R, O'Neill, Charles A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309/ https://www.ncbi.nlm.nih.gov/pubmed/24938720 http://dx.doi.org/10.1002/jnr.23423

Ejemplares similares

Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis
por: Meiman, Elizabeth J., et al.
Publicado: (2022)

CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)
por: Eaton, S. L., et al.
Publicado: (2019)

Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression
por: Katz, M L, et al.
Publicado: (2017)

A Missense Mutation in Canine CLN6 in an Australian Shepherd with Neuronal Ceroid Lipofuscinosis
por: Katz, Martin L., et al.
Publicado: (2011)

Etiology of anxious and fearful behavior in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)
por: Ostergaard, John R.
Publicado: (2023)

Australian Cattle Dogs with Neuronal Ceroid Lipofuscinosis are Homozygous for a CLN5 Nonsense Mutation Previously Identified in Border Collies
por: Kolicheski, A., et al.
Publicado: (2016)

Novel CLN1 mutation with atypical juvenile neuronal ceroid lipofuscinosis
por: Khan, Arif, et al.
Publicado: (2013)

An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy
por: Thompson, Dorothy A., et al.
Publicado: (2021)

in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels
por: Mohammed, Alamin, et al.
Publicado: (2017)

Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis
por: Murray, Samantha J, et al.
Publicado: (2023)

Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
por: Sindelar, Miriam, et al.
Publicado: (2018)

Correction: An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy
por: Thompson, Dorothy A., et al.
Publicado: (2021)

Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis
por: Lopez-Fabuel, Irene, et al.
Publicado: (2022)

Novel likely disease-causing CLN5 variants identified in Pakistani patients with neuronal ceroid lipofuscinosis
por: Azad, Beenish, et al.
Publicado: (2020)

Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice
por: Blom, Tea, et al.
Publicado: (2013)

A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis
por: Basak, I., et al.
Publicado: (2021)

Treatment of non-epileptic episodes of anxious, fearful behavior in adolescent juvenile neuronal ceroid lipofuscinosis (CLN3 disease)
por: Ostergaard, John R.
Publicado: (2023)

Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease
por: Gardner, Emily, et al.
Publicado: (2019)

Two cases of variant late infantile ceroid lipofuscinosis in Jordan
por: Nafi, Omar, et al.
Publicado: (2019)

Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins
por: Lyly, Annina, et al.
Publicado: (2009)

The neuronal ceroid lipofuscinosis protein Cln7 functions in the postsynaptic cell to regulate synapse development
por: Connolly, Kyle J., et al.
Publicado: (2019)

Autophagy–lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease
por: Adams, Jessie, et al.
Publicado: (2019)

Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis
por: Kanninen, Katja M., et al.
Publicado: (2013)

Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients
por: Makoukji, Joelle, et al.
Publicado: (2015)

Neuronal ceroid lipofuscinosis in a German Shorthaired Pointer associated with a previously reported CLN8 nonsense variant
por: Guo, Juyuan, et al.
Publicado: (2019)

Aggregation chimeras provide evidence of in vivo intercellular correction in ovine CLN6 neuronal ceroid lipofuscinosis (Batten disease)
por: Barry, Lucy Anne, et al.
Publicado: (2022)

Functional Analysis of a Novel CLN5 Mutation Identified in a Patient With Neuronal Ceroid Lipofuscinosis
por: Luo, Sukun, et al.
Publicado: (2020)

Rare adult neuronal ceroid lipofuscinosis associated with CLN6 gene mutations: A case report
por: Wang, Xue-Qiang, et al.
Publicado: (2023)

Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin
por: Minye, Helena M., et al.
Publicado: (2016)

Pacemaker Implantation in Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)–A Long-Term Follow-Up Study
por: Handrup, Mette Møller, et al.
Publicado: (2022)

Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica’s experience
por: Badilla-Porras, R., et al.
Publicado: (2022)

Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease)
por: Wang, Qing Jun, et al.
Publicado: (2020)

Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease
por: Purzycka-Olewiecka, Joanna Karolina, et al.
Publicado: (2022)

Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset
por: Groh, Janos, et al.
Publicado: (2021)

A Drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism
por: Imler, Elliot, et al.
Publicado: (2019)

CLN8 Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis—Literature Review and Case Report
por: Badura-Stronka, Magdalena, et al.
Publicado: (2021)

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis
por: Huhtala, Tuulia, et al.
Publicado: (2012)

Late infantile neuronal ceroid lipofuscinosis: A case report with review of literature
por: Verma, Rajesh, et al.
Publicado: (2013)

Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model
por: Koster, Kevin P, et al.
Publicado: (2019)

Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfa
por: Schaefers, J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pfg347h8gnivc8mjg09mmtb28d